Combining Ellagic Acid with Bevacizumab Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Model


Cetin A., Biltekin B.

ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, vol.41, no.3, pp.75-82, 2019 (SCI-Expanded, Scopus) identifier identifier

Abstract

OBJECTIVE: To observe the combining effect of ellagic acid (EA) with bevacizumab (BEV) on cadherin switch and angiogenesis of C6-glioma cell line.